Concepedia

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

Han‐Seung Yoon, Nathan R. Foster, J. Meyers, Preston D. Steen, Daniel W. Visscher, Raji Pillai, Debra M. Prow, Christopher M. Reynolds, Benjamin T. Marchello, Rex B. Mowat,

Annals of Oncology · 2015 · 57 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

John D. Hainsworth, Mark S. Rubin, David R. Spigel et al. · Journal of Clinical Oncology · 2012 · 372 citations · Full text

, , +17

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site

Jeffrey S. Ross, Kai Wang, Laurie M. Gay et al. · JAMA Oncology · 2015 · 249 citations · Full text

, , +17

Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation

Gauri R. Varadhachary, Dmitri Talantov, Martin N. Raber et al. · Journal of Clinical Oncology · 2008 · 237 citations

, , +16

Carboplatin Plus Paclitaxel in Unknown Primary Carcinoma: A Phase II Hellenic Cooperative Oncology Group Study

Evangelos Briasoulis, D. Bafaloukos, E. Samantas et al. · Journal of Clinical Oncology · 2000 · 203 citations

, , +15

Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin

Federico A. Monzon, Maureen A. Lyons‐Weiler, Ljubomir Buturović et al. · Journal of Clinical Oncology · 2009 · 198 citations

, , +17